The Effect of Combined Surgery in Management of Congenital Pseudarthrosis of Tibia

NCT02640040 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2020-10-22

No results posted yet for this study

Summary

The study aims to evaluate the clinical result of Combined Surgery in Management of Congenital Pseudarthrosis.

Conditions

  • Congenital Pseudarthrosis of Tibia

Interventions

DEVICE

llizarov external fixation device

llizarov external fixation device was applied to fix the tibia.

DEVICE

intramedullary rod fixation

retrograde intramedullary rod was applied to stabilize the tibia.

PROCEDURE

surgery

combined surgery for enrolled patients with CPT: sleeve resection of the pathological soft tissues, retrograde intramedullary rodding, packaged lilac bone autograft,and llizarov external fixation device installation.

Sponsors & Collaborators

  • Guangzhou Women and Children's Medical Center

    collaborator OTHER
  • Shenzhen Children's Hospital

    collaborator OTHER_GOV
  • Tongji Hospital

    collaborator OTHER
  • Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

    collaborator OTHER
  • Wuhan Women and Children's Medical Center

    collaborator OTHER
  • Foshan Hospital of Traditional Chinese Medicine

    collaborator OTHER
  • Beijing Children's Hospital

    collaborator OTHER
  • Dalian Children's Hospital

    collaborator OTHER
  • Children's Hospital of Chongqing Medical University

    collaborator OTHER
  • Kunming Children's Hospital

    collaborator OTHER
  • Hunan Children's Hospital

    lead OTHER_GOV

Principal Investigators

  • Xu Yao · Hunan Children's Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
2 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-08-31
Primary Completion
2025-12-31
Completion
2025-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02640040 on ClinicalTrials.gov